Properties and pharmacokinetics of two humanized antibodies specific for L-selectin

Immunotechnology

Volumn 4, Issue 3-4, 1999, Pages 253-266

  Co, Man Sung ^a   Landolfi, Nicholas F ^a   Nagy, Jon O ^b   Tan, Jennifer H ^b   Vexler, Vladimir ^a   Vasquez, Max ^a   Roark, Linda ^a   Yuan, Shauna ^a   Hinton, Paul R ^a   Melrose, Jennifer ^a   Klingbeil, Corine ^a   Queen, Cary ^a   Berg, Ellen L ^a  

^a PROTEIN DESIGN LABS INC   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Adhesion; Antibodies; Humanization; L Selectin; Pharmacokinetics

Indexed keywords

ANTIINFLAMMATORY AGENT; L SELECTIN; MONOCLONAL ANTIBODY DREG 200; MONOCLONAL ANTIBODY DREG 55; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; DRUG HALF LIFE; IMMUNOGENICITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; CELL ADHESION; CLONING, MOLECULAR; CROSS REACTIONS; ENDOTHELIUM, LYMPHATIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; L-SELECTIN; LEUKOCYTES; LIPOSOMES; MACACA MULATTA; MICE; MOLECULAR SEQUENCE DATA; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; TRANSFECTION;

EID: 0033103206     PISSN: 13802933     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1380-2933(98)00024-4     Document Type: Article

References (41)

1. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood. 88(9):1996;3259-3287.
2. Kishimoto T.K., Warnock R.A., Jutila M.A., Butcher E.C., Lane C., Anderson D.C., Smith C.W. Antibodies against human neutrophil LECAM-1 (LAM-1Leu-8/Dreg-56 antigen) and endothelial cell ELAM-1 inhibit a common CD18-independent adhesion pathway in vitro. Blood. 78:1991;805-811.
3. Luscinskas F.W., Ding H., Tan P., Cumming D., Tedder T.F., Gerritsen M.E. L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-α-activated vascular endothelium under flow in vitro. J. Immunol. 156:1996;326-335.
4. Knol E.F., Tackey F., Tedder T.F., Klunk D.A., Bickel C.A., Sterbinsky S.A., Bochner B.S. Comparison of human eosinophil and neutrophil adhesion to endothelial cells under nonstatic conditions. Role of L-selectin. J. Immunol. 153:1994;2161-2167.
5. Gallatin W.M., Weissman I.L., Butcher E.C. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 303:1983;30-34.
6. Michie S.A., Streeter P.R., Bolt P.A., Butcher E.C., Picker L.J. The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am. J. Pathol. 143:1993;1688-1698.
7. Simon S.I., Chambers J.D., Butcher E.C., Sklar L.A. Neutrophil aggregation is β2-integrin and L-selectin-dependent in blood and isolated cells. J. Immunol. 149:1992;765-2771.
8. Ma X.-L., Weyrich A.S., Lefer D.J., Buerke M., Albertine K.H., Kishimoto T.K., Lefer A.M. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation. 88:1993;649-658.
9. Buerke M., Weyrich A.S., Murohara T., Queen C., Klingbeil C.K., Co M.S., Lefer A.M. Humanized monoclonal antibody DREG-200 directed against L-selectin protects in feline myocardial reperfusion injury. J. Pharmacol. Exp. Ther. 271:1994;134-142.
10. Mulligan M.S., Miyasaka M., Tamatani T., Jones M.L., Ward P.A. Requirements for L-selectin in neutrophil-mediated lung injury in rats. J. Immunol. 152:1994;832-840.
11. Mulligan M.S., Till G.O., Smith C.W., Anderson D.C., Miyasaka M., Tamatani T., Todd R.F., Issekutz T.B., Ward P.A. Role of leukocyte adhesion molecules in lung and dermal vascular injury after thermal trauma of skin. Am. J. Pathol. 144:1994;1008-1015.
12. Seekamp A., Till G.O., Mulligan M.S., Paulson J.C., Anderson D.C., Miyasaka M., Ward P.A. Role of selectins in local and remote tissue injury following ischemia and reperfusion. Am. J. Pathol. 144:1994;592-598.
13. Mihelcic D., Schleiffenbaum B., Tedder T.F., Sharar S.R., Harlan J.M., Winn R.K. Inhibition of leukocyte L-selectin function with a monoclonal antibody attenuates reperfusion injury to the rabbit ear. Blood. 84:1994;2322-2328.
14. Ramamoorthy C., Sharar S.R., Harlan J.M., Tedder T.F., Winn R.K. Blocking L-selectin function attenuates reperfusion injury following hemorrhagic shock in rabbits. Am. J. Physiol. 271:1996;1871-1877.
15. DiMaggio J.J., Scheinberg D.A., Houghton A.N. Monoclonal antibody therapy of cancer. Cancer Chemother. Biol. Response Modif. 11:1990;177-203.
16. Winter G.P. Antibody engineering. Philos. Trans. R. Soc. London Ser. B. 324:1989;537-546.
17. Queen C., Schneider W.P., Selick H.E., Payne P.W., Landolfi N.F., Duncan J.F., Avdalovic N.M., Levitt M., Junghans R.P., Waldmann T.A. A humanized antibody that binds to interleukin-2 receptor. Proc. Natl. Acad. Sci. USA. 86:1989;10029-10033.
18. Vincenti F., Kirkman R., Light S., Bumgardner G., Pescovitz M., Halloran P., Neylan H., Wilkinson A., Ekberg H., Gaston R., Backman L., Burdick J. Interleukin-2-receptor blockade with daclizumab to prevent acture rejection in renal transplantation. New Engl. J. Med. 338:1998;161-165.
19. Caron P.C., Jurcic J.G., Scott A.M., Finn R.D., Divgi C.R., Graham M.C., Jureidini I.M., Sqouros G., Tyson D., Old L.J., Larson S.M., Scheinberg D.A. A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific trageting without immunogenecity. Blood. 83:1994;1760-1768.
20. Subramanian K.N.S., Weisman L.E., Hrodes T., Ariagno R., Sanchez R.J., Steichen J., Givner L.B., Jennings T.L., Top F.H., Carlin D., Connor E. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. Pediatr. Infect. Dis. J. 17:1998;110-115.
21. Kishimoto T.K., Jutila M.A., Butcher E.C. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc. Natl. Acad. Sci. USA. 87:1990;2244-2248.
22. Spevak W., Foxall C., Charych D.H., Dasgupta F., Nagy J.O. Carbohydrates in an acidic multivalent assembly: nanomolar P-selectin inhibitors. J. Med. Chem. 39(5):1996;1018-1020.
23. Co M.S., Avdalovic N.M., Caron P.C., Avdalovic M.V., Scheinberg D.A., Queen C. Chimeric and humanized antibodies with specificity for the CD33 antigen. J. Immunol. 148:1992;1149-1154.
24. Levitt M. Molecular dynamics of native protein. 1. Computer simulation of trajectories. J. Mol. Biol. 168:1983;595-617.
25. Zilber B., Scherf T., Levitt M., Anglister J. NMR-derived model for a peptide antibody complex. Biochemistry. 29:1990;10032-10041.
26. Glaser S.M., Vasquez M., Payne P.W., Schneider W.P. Dissection of the combining site in a humanized anti-Tac antibody. J. Immunol. 149:1992;2607-2614.
27. He X., Xu Z., Melrose J., Mullowney A.M., Vasquez M., Queen C., Vexler V., Klingbeil C., Co M.S., Berg E.L. Humanization and pharmacokinetics of a mouse monoclonal antibody with specificity for both E- and P-selectin. J. Immunol. 160:1998;1029-1035.
28. Berg E.L., Fromm C., Melrose J., Tsurushita N. Antibodies cross-reactive with E- and P-selectin block both E- and P-selectin functions. Blood. 85:1995;31-37.
29. Marchalonis J.J. An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem. J. 113:1969;299-305.
30. Berzofsky J.A., Berkower I.J., Epstein S.L. Antigen-antibody interactions and monoclonal antibodies. Paul W.E. Fundamental Immunology. 3rd ed. 1993;421-424 Raven Press, New York.
31. Streeter P.R., Berg E.L., Rouse B.T., Bargatze R.F., Butcher E.C. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature. 331(6151):1988;41-46.
32. Kabat E.A., Wu T.T., Perry H.M., Gottesman K.S., Foeller C. Sequences of Proteins of Immunological Interest. 5th ed. 1991;National Institutes of Health, Bethesda, MD.
33. Wu N.W., Jalkanen S., Streeter P.R., Butcher E.C. Evolutionary conservation of tissue-specific lymphocyte-endothelial cell recognition mechanisms involved in lymphocyte homing. J. Cell Biol. 107:1988;1845-1851.
34. Berg E.L., Magnani J., Warnock R.A., Robinson M.A., Butcher E.C. Comparison of L-selectin and E-selectin ligand specificities: the L-selectin can bind the E-selectin ligands sialyl Lewis x and sialyl Lewis a. Biochem. Biophys. Res. Commun. 184:1992;1048-1055.
35. Feizi T. Blood group-related oligosaccharides are ligands in cell-adhesion events. Biochem. Soc. Trans. 20(2):1992;274-278.
36. Varki A. Selectin ligands. Proc. Natl. Acad. Sci. USA. 91:1994;7390-7397.
37. Fu H., Berg E.L., Tsurushita N. Fine mapping of the epitopes of humanized anti-L-selectin monoclonal antibodies HuDREG-55 and HuDREG-200. Immunol. Lett. 58:1997;71-77.
38. Stamper H.B. Jr., Woodruff J.J. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J. Exp. Med. 144(3):1976;828-833.
39. Gopalan P.K., Smith C.W., Lu H., Berg E.L., McIntire L.V., Simon S.I. Neutrophil CD18-dependent arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow can be activated through L-selectin. J. Immunol. 158(1):1997;367-375.
40. Morell A., Terry W.D., Waldmann T.A. Metabolic properties of IgG subclasses in man. J. Clin. Invest. 49:1970;673-680.
41. Hakimi J., Chizzonite R., Luke D.R., Familletti P.C., Bailon P., Kondas J.A., Pilson R.S., Lin P., Weber D., Spence C., Mondini L.J., Tsien W., Levin J.L., Gallati V.H., Korn L., Waldmann T.A., Queen C., Benjamin W.R. Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys. J. Immunol. 147:1991;1352-1359.